ab34710 Search Results


anti-collagen-1 (ab-34710)  (WuXi AppTec)
90
WuXi AppTec anti-collagen-1 (ab-34710)
( A ) Overall survival after resection and neoadjuvant FOLFIRINOX or gemcitabine-based chemotherapy in patients presenting with borderline or non-resectable pancreatic cancer. The median (95% confidence interval) survival was 31.6 (24.5–44.5) months after FOLFIRINOX ( n = 11) versus 15.8 (2.0–20.5) months after gemcitabine-based therapy ( n = 13) ( p = 0.039). ( B ) Representative H&E stained tissues (top), and IF (bottom) for DAPI (blue) and CK-7 + tumor cells (red), as well as representative FACS-like co-expression scattergrams and quantitation of CK-7 + cells per area in mm 2 are blotted as mean with 95% CI as shown in . ( C ) Representative trichrome stained tissues for <t>collagen-1,</t> as well as representative FACS-like co-expression scattergrams and quantitation of collagen-1 expression per area mm 2 are blotted as mean with 95% CI as shown in . ( D ) Representative IF stained tissues for collagen-1 (green), DAPI (blue) and CK-7 + tumor cells (red), as well as representative FACS-like co-expression scattergrams and quantitation of collagen-1 expression per area mm 2 are blotted as mean with 95% CI as shown in . ( E ) Representative IF stained tissues for αSMA (green), DAPI (blue) and CK-7 + tumor cells (red), as well as representative FACS-like co-expression scattergrams and quantitation of αSMA and are blotted as mean with 95% CI as shown in . ( F ) The mean (95% CI) activated stromal index (ratio of αSMA to collagen-1) by group. Human tissue scale bar = 20 μm, 20× objective. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Anti Collagen 1 (Ab 34710), supplied by WuXi AppTec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ab34710/pmc06944451-168-0-5?v=WuXi+AppTec
Average 90 stars, based on 1 article reviews
anti-collagen-1 (ab-34710) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


( A ) Overall survival after resection and neoadjuvant FOLFIRINOX or gemcitabine-based chemotherapy in patients presenting with borderline or non-resectable pancreatic cancer. The median (95% confidence interval) survival was 31.6 (24.5–44.5) months after FOLFIRINOX ( n = 11) versus 15.8 (2.0–20.5) months after gemcitabine-based therapy ( n = 13) ( p = 0.039). ( B ) Representative H&E stained tissues (top), and IF (bottom) for DAPI (blue) and CK-7 + tumor cells (red), as well as representative FACS-like co-expression scattergrams and quantitation of CK-7 + cells per area in mm 2 are blotted as mean with 95% CI as shown in . ( C ) Representative trichrome stained tissues for collagen-1, as well as representative FACS-like co-expression scattergrams and quantitation of collagen-1 expression per area mm 2 are blotted as mean with 95% CI as shown in . ( D ) Representative IF stained tissues for collagen-1 (green), DAPI (blue) and CK-7 + tumor cells (red), as well as representative FACS-like co-expression scattergrams and quantitation of collagen-1 expression per area mm 2 are blotted as mean with 95% CI as shown in . ( E ) Representative IF stained tissues for αSMA (green), DAPI (blue) and CK-7 + tumor cells (red), as well as representative FACS-like co-expression scattergrams and quantitation of αSMA and are blotted as mean with 95% CI as shown in . ( F ) The mean (95% CI) activated stromal index (ratio of αSMA to collagen-1) by group. Human tissue scale bar = 20 μm, 20× objective. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Journal: Oncotarget

Article Title: Effects of neoadjuvant FOLFIRINOX and gemcitabine-based chemotherapy on cancer cell survival and death in patients with pancreatic ductal adenocarcinoma

doi: 10.18632/oncotarget.27399

Figure Lengend Snippet: ( A ) Overall survival after resection and neoadjuvant FOLFIRINOX or gemcitabine-based chemotherapy in patients presenting with borderline or non-resectable pancreatic cancer. The median (95% confidence interval) survival was 31.6 (24.5–44.5) months after FOLFIRINOX ( n = 11) versus 15.8 (2.0–20.5) months after gemcitabine-based therapy ( n = 13) ( p = 0.039). ( B ) Representative H&E stained tissues (top), and IF (bottom) for DAPI (blue) and CK-7 + tumor cells (red), as well as representative FACS-like co-expression scattergrams and quantitation of CK-7 + cells per area in mm 2 are blotted as mean with 95% CI as shown in . ( C ) Representative trichrome stained tissues for collagen-1, as well as representative FACS-like co-expression scattergrams and quantitation of collagen-1 expression per area mm 2 are blotted as mean with 95% CI as shown in . ( D ) Representative IF stained tissues for collagen-1 (green), DAPI (blue) and CK-7 + tumor cells (red), as well as representative FACS-like co-expression scattergrams and quantitation of collagen-1 expression per area mm 2 are blotted as mean with 95% CI as shown in . ( E ) Representative IF stained tissues for αSMA (green), DAPI (blue) and CK-7 + tumor cells (red), as well as representative FACS-like co-expression scattergrams and quantitation of αSMA and are blotted as mean with 95% CI as shown in . ( F ) The mean (95% CI) activated stromal index (ratio of αSMA to collagen-1) by group. Human tissue scale bar = 20 μm, 20× objective. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Article Snippet: Anti-Collagen-1 (ab-34710) was purchased from Abgent (San Diego, USA).

Techniques: Staining, Expressing, Quantitation Assay